Robert Hindes MD

Dr. Robert Hindes of Southbury, Connecticut, maintains a long history of overseeing pharmaceutical research and clinical trials as a Principal Investigator and Sub-Investigator. The recipient of a Doctor of Medicine from the Robert Wood Johnson Medical School at Rutgers, The State University of New Jersey, Dr. Hindes worked as an Assistant Clinical Professor of Medicine and an Infectious Disease Consultant for more than a decade before leading research at pharmaceutical firms Bristol-Myers Squibb (BMS) and Pharmasset, Inc. Outside of work, Robert Hindes, M.D., engages in continuing education and networking as a member of several professional societies.

Dr. Robert Hindes most recently managed clinical trials at Princeton, New Jersey-based Pharmasset, where he served as the Vice President of Clinical Development from 2011 to 2012. During his time at the company, Dr. Hindes directly coordinated strategic development of a phase III clinical trials program and an affiliated filing strategy, and he led regulatory compliance initiatives and interactions with the U.S. Food and Drug Administration and various European health authorities. He also supervised Pharmasset's medical monitors, contract employees, and contract research organization partners. Prior to Pharmasset, Dr. Hindes held various research director positions with BMS. Based at the drug manufacturer's Pharmaceutical Research Institute in Connecticut, he started out as an Associate Director of Infectious Diseases. From 2004 to 2011, Robert Hindes, M.D., worked first as a BMS Director of Virology and later as a Group Director of the company's Virology program. During that time, he coordinated clinical trials for a long-term drug treatment for chronic hepatitis B and he led phase II and phase III trials for an antiviral medication for hepatitis C.

Currently, Dr. Robert Hindes holds a Connecticut physician's license, and he maintains certification with the American Board of Internal Medicine (ABIM) and the ABIM Subspecialty Board on Infectious Disease. He also belongs to the American College of Physicians and the Connecticut Infectious Disease Society.